Approval · Notice of Compliance 22398 · 2019
PROBUPHINE: Notice of Compliance 22398
Issued July 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22398
- Date
- July 12, 2019
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new site and process for terminal sterilization of the implants
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROBUPHINE | Not yet assigned | — |
Medicinal ingredients
- BUPRENORPHINE HYDROCHLORIDE 80 MG per IMP